The EMA’s Orphan Medicines Office is hosting an interactive webinar on Rare Disease Day on 29 February 2024, to answer questions that developers of products for rare diseases or researchers in this field might have on orphan designations and rare disease development. The webinar will feature:
- short presentations on the background of orphan designation and the benefits it has brought to patients;
- a live question-and-answer session enabling participants to ask their questions on orphan medicines development to a panel of regulatory experts.
|Orphan Medicines Development – ask the European regulator webinar
|February 29th, 2024
|16:00 – 17:30 hr
|European Medicines Agency